Skip to main content
. 2022 Aug 9;12:963928. doi: 10.3389/fonc.2022.963928

Figure 1.

Figure 1

BI 2536 inhibits ovarian cancer cells growth in vitro (A) Half-maximal inhibitory concentration curves of BI 2536 evaluated by CCK-8 assay. (B) Colony formation assay of A2780 treated with the indicated concentration of BI 2536. (C, D) Flow cytometry analysis of the proportion of different cell cycle phases in treated A2780 cells. (E) Representative images showing fluorescence staining of BI 2536-treated cells using EdU proliferation assay. **P < 0.01, and ***P < 0.001.